• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植后不久,巨细胞病毒(CMV)血症风险与供者来源造血干细胞移植后受者的血浆中 torque teno 病毒(TTV)DNA 载量动力学有关。

The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

机构信息

Microbiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.

Hematology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.

出版信息

Bone Marrow Transplant. 2018 Feb;53(2):180-187. doi: 10.1038/bmt.2017.235. Epub 2017 Oct 30.

DOI:10.1038/bmt.2017.235
PMID:29084205
Abstract

Monitoring Torque teno virus (TTV) DNA load helps to estimate the risk of opportunistic infections in solid organ transplant recipients. We investigated whether the early kinetic pattern of plasma TTV DNA load after allogeneic hematopoietic stem cell transplantation (allo-HSCT) associates with subsequent CMV and EBV DNAemia. This study included 71 allo-HSCT patients. We found that the area under the curve (AUC) for log TTV DNA loads quantified by days 20 and 30 after transplantation (TTV DNA load AUC), was significantly lower (P=0.036) in patients who subsequently developed CMV DNAemia requiring preemptive antiviral therapy (n=17) than in those who did not (n=8) or had no CMV DNAemia (n=19). Patients displaying TTV DNA load AUC⩽2.8 copies × days × mL were more likely to have high-level CMV DNAemia. A trend towards a direct correlation between TTV DNA AUC and CMV-specific interferon-γ CD8+ T-cell counts by day +30 was noted (P=0.095). However, this dynamic parameter was not useful for anticipating the occurrence of either CMV recurrences (n=12) or EBV DNAemia (n=34). In summary, it may be possible to identify a subset of allo-HSCT patients at a high risk of developing high-level CMV DNAemia by analyzing the kinetics of plasma TTV DNA load early after engraftment.

摘要

监测扭结瘤病毒(TTV)DNA 载量有助于评估实体器官移植受者发生机会性感染的风险。我们研究了异基因造血干细胞移植(allo-HSCT)后血浆 TTV DNA 载量的早期动力学模式是否与随后的 CMV 和 EBV DNA 血症相关。这项研究纳入了 71 例 allo-HSCT 患者。我们发现,移植后第 20 天和第 30 天定量的 TTV DNA 载量的曲线下面积(TTV DNA 载量 AUC)在随后发生需要抢先抗病毒治疗的 CMV DNA 血症(n=17)的患者中明显低于未发生 CMV DNA 血症(n=8)或未发生 CMV DNA 血症(n=19)的患者(P=0.036)。TTV DNA 载量 AUC ⩽2.8 拷贝×天×毫升的患者更有可能发生高水平 CMV DNA 血症。TTV DNA AUC 与移植后第 30 天的 CMV 特异性干扰素-γ CD8+ T 细胞计数之间存在直接相关性的趋势(P=0.095)。然而,该动态参数对于预测 CMV 复发(n=12)或 EBV DNA 血症(n=34)的发生均无意义。总之,通过分析移植后早期血浆 TTV DNA 载量的动力学,可能可以识别出一组 allo-HSCT 患者发生高水平 CMV DNA 血症的风险较高。

相似文献

1
The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.移植后不久,巨细胞病毒(CMV)血症风险与供者来源造血干细胞移植后受者的血浆中 torque teno 病毒(TTV)DNA 载量动力学有关。
Bone Marrow Transplant. 2018 Feb;53(2):180-187. doi: 10.1038/bmt.2017.235. Epub 2017 Oct 30.
2
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.异基因干细胞移植受者中细小病毒B19血浆DNA血症的动态变化
J Clin Virol. 2017 Sep;94:22-28. doi: 10.1016/j.jcv.2017.07.001. Epub 2017 Jul 8.
3
Kinetics of Alphatorquevirus plasma DNAemia at late times after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后晚期阿尔法反转录病毒血浆 DNA 血症的动力学。
Med Microbiol Immunol. 2019 Apr;208(2):253-258. doi: 10.1007/s00430-019-00586-w. Epub 2019 Mar 9.
4
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.评估血浆 Torque Teno 病毒 DNA 载量监测对小分子抑制剂治疗血液系统恶性肿瘤患者巨细胞病毒 DNA 血症的预测价值:一项概念验证研究。
J Med Virol. 2023 Jul;95(7):e28933. doi: 10.1002/jmv.28933.
5
Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.血浆中炎症生物标志物的动力学可预测异基因造血干细胞移植受者巨细胞病毒 DNA 血症发作的发生和特征。
Med Microbiol Immunol. 2019 Aug;208(3-4):405-414. doi: 10.1007/s00430-019-00594-w. Epub 2019 Mar 25.
6
Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting.监测血浆中的 Torque teno 病毒、全微小病毒科和人类 Pegivirus 1 病毒载量,以预测异基因造血干细胞移植中的感染事件和急性移植物抗宿主病。
J Med Virol. 2023 Sep;95(9):e29107. doi: 10.1002/jmv.29107.
7
The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.Torque Teno 病毒载量与儿童和青少年肾移植患者巨细胞病毒和 BKV 感染的关系。
J Clin Virol. 2024 Jun;172:105673. doi: 10.1016/j.jcv.2024.105673. Epub 2024 Mar 26.
8
Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation.同种异体造血干细胞移植后唾液和血浆中扭结藤病毒 DNA 载量的动力学。
J Med Virol. 2018 Sep;90(9):1438-1443. doi: 10.1002/jmv.25218. Epub 2018 May 25.
9
Torque teno virus-DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation.Torque teno 病毒-DNA 载量作为异基因造血干细胞移植后个体巨细胞病毒风险评估参数。
Eur J Haematol. 2023 Dec;111(6):963-969. doi: 10.1111/ejh.14111. Epub 2023 Sep 29.
10
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation.粪便中 TT 病毒 DNA 的动力学变化可能有助于在异基因造血干细胞移植后早期预测急性肠道移植物抗宿主病的发生。
Transpl Infect Dis. 2021 Jun;23(3):e13507. doi: 10.1111/tid.13507. Epub 2020 Nov 27.

引用本文的文献

1
Torque Teno Virus: Lights and Shades.细小病毒:明暗交织
Viruses. 2025 Feb 27;17(3):334. doi: 10.3390/v17030334.
2
Viral Infections in HSCT Recipients with Post-Transplant Lymphoproliferative Disorder: The Role of Torque Teno Virus as a Marker of Immune Functions.接受造血干细胞移植后发生移植后淋巴增殖性疾病的患者中的病毒感染:细小病毒B19作为免疫功能标志物的作用。
Microorganisms. 2025 Feb 2;13(2):326. doi: 10.3390/microorganisms13020326.
3
Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients.扭结张力病毒:肾移植受者有前途的生物标志物。

本文引用的文献

1
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.异基因干细胞移植受者中细小病毒B19血浆DNA血症的动态变化
J Clin Virol. 2017 Sep;94:22-28. doi: 10.1016/j.jcv.2017.07.001. Epub 2017 Jul 8.
2
Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.Torque Teno 病毒血症动力学可预测异基因造血干细胞移植后并发症的风险。
Med Microbiol Immunol. 2017 Oct;206(5):355-362. doi: 10.1007/s00430-017-0511-4. Epub 2017 Jul 12.
3
Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
Int J Mol Sci. 2024 Jul 15;25(14):7744. doi: 10.3390/ijms25147744.
4
Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects.血液中扭转型病毒 DNA 载量作为成人血液系统疾病患者免疫状态的生物标志物:现状与未来展望。
Viruses. 2024 Mar 17;16(3):459. doi: 10.3390/v16030459.
5
Understanding torquetenovirus (TTV) as an immune marker.将Torque teno病毒(TTV)理解为一种免疫标志物。
Front Med (Lausanne). 2023 Jun 13;10:1168400. doi: 10.3389/fmed.2023.1168400. eCollection 2023.
6
Identification of Torquetenovirus Species in Patients with Kawasaki Disease Using a Newly Developed Species-Specific PCR Method.应用新型种特异性 PCR 方法鉴定川崎病患者中的托奇病毒种属。
Int J Mol Sci. 2023 May 12;24(10):8674. doi: 10.3390/ijms24108674.
7
Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?对 COVID-19 危重症患者进行 Torque Teno 病毒 DNA 血症监测:是否有助于预测临床结局?
J Clin Virol. 2022 Mar;148:105082. doi: 10.1016/j.jcv.2022.105082. Epub 2022 Jan 23.
8
Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation.人巨细胞病毒感染:异基因造血干细胞移植后的一个重要问题。
Oncol Lett. 2021 Apr;21(4):318. doi: 10.3892/ol.2021.12579. Epub 2021 Feb 23.
9
Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications.造血干细胞移植中的病毒感染:检测、监测、临床管理及免疫学意义
Front Immunol. 2021 Jan 20;11:569381. doi: 10.3389/fimmu.2020.569381. eCollection 2020.
10
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.Torque Teno 病毒作为异基因造血干细胞移植后并发症和生存的潜在生物标志物。
Front Immunol. 2020 May 27;11:998. doi: 10.3389/fimmu.2020.00998. eCollection 2020.
巨细胞病毒血症对异基因干细胞移植受者总体死亡率和无复发生存率的影响。
Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12717. Epub 2017 Jun 20.
4
Comparison of the artus Epstein-Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients.比较阿图斯爱泼斯坦-巴尔病毒(EBV)PCR试剂盒与雅培实时EBV检测法在测量异基因干细胞移植受者血浆EBV DNA载量方面的差异。
Diagn Microbiol Infect Dis. 2017 May;88(1):36-38. doi: 10.1016/j.diagmicrobio.2017.02.010. Epub 2017 Feb 24.
5
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.原位肝移植后扭矩细小病毒载量与急性排斥反应
Transplantation. 2017 Jul;101(7):e219-e221. doi: 10.1097/TP.0000000000001723.
6
Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.细小病毒B19载量与肾移植后抗体介导性排斥反应呈负相关。
Transplantation. 2017 Feb;101(2):360-367. doi: 10.1097/TP.0000000000001455.
7
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients.基于病毒学和免疫学联合监测的抢先抗病毒治疗策略对异基因干细胞移植受者活动性巨细胞病毒感染的疗效和安全性
Open Forum Infect Dis. 2016 May 18;3(2):ofw107. doi: 10.1093/ofid/ofw107. eCollection 2016 Apr.
8
Torquetenovirus: the human virome from bench to bedside.Torquetenovirus:从实验室到临床的人类病毒组。
Clin Microbiol Infect. 2016 Jul;22(7):589-93. doi: 10.1016/j.cmi.2016.04.007. Epub 2016 Apr 16.
9
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.抢先治疗时代造血干细胞移植后巨细胞病毒载量与死亡率:一项回顾性队列研究
Lancet Haematol. 2016 Mar;3(3):e119-27. doi: 10.1016/S2352-3026(15)00289-6. Epub 2016 Feb 20.
10
Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.根据血液中病毒倍增时间指导的异基因干细胞移植受者巨细胞病毒感染的抢先抗病毒治疗。
Bone Marrow Transplant. 2016 May;51(5):718-21. doi: 10.1038/bmt.2015.303. Epub 2015 Dec 7.